PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 11, 2026Pediatric Diabetes3 citationsOpen Access

Is the Current Screening Availability for Early Stages of Type 1 Diabetes in Germany Related to the Population‐Based Frequency of Diabetic Ketoacidosis at Clinical Manifestation in Children and Adolescents

View Full Paper
AEAlexander J. EckertJRJ RosenbauerCKClemens Kamrath

Key Points

  • This research aims to evaluate whether screening for early-stage type 1 diabetes is linked to the incidence of diabetic ketoacidosis at diagnosis in children and adolescents in Germany.
  • Included children aged 0.5 to <15 years diagnosed with type 1 diabetes from 2015-2023.
  • Allocated participants to federal states based on postal code.
  • Calculated relative risk for diabetic ketoacidosis using logistic regression models.
  • Included 24,408 children, median onset age 8.8 years, with no significant difference in DKA rates between states with and without screening.
  • In a subgroup with a higher likelihood of screening, a significantly lower DKA rate was observed (RR: 0.88).
  • The strongest predictor for DKA was age at manifestation being less than 3 years (RR: 1.83).

Abstract

Aims Is the current screening for early‐stage type 1 diabetes (T1D) associated with the rate of diabetic ketoacidosis (DKA) at T1D manifestation at population level? Materials and Methods Children with T1D manifestation in 2015–2023 in Germany, aged 0.5 to <15 years from the multicenter diabetes registry (DPV) were included and allocated to federal states (FSs) based on their residential postal code. The relative risk (RR) with 95% confidence interval for DKA at manifestation of T1D by FS with vs. without screening, and demographic/context factors was calculated using logistic regression models. Results 24,408 children (54.3% males) were included with median onset age of 8.8 (quartiles: 5.3; 11.8) years. The RR for DKA was not significantly lower in FS with vs. without screening (RR: 0.96 0.93–1.03, p = 0.393) overall, but in the sub‐group of children with the highest probability of being screened (age 1.75–10.99 years, manifestation in Bavaria from 2020 to 2023, RR: 0.88 0.80–0.97, p = 0.012). The most important predictor for DKA was manifestation age <3 years (RR: 1.83, 1.66–2.03, p < 0.001). Conclusions Until 2023, current regional screening initiatives for early‐stage T1D were not associated with lower frequency of DKA at population level, but might be helpful in the future if the coverage can be markedly increased.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Eckert et al. (2026) studied this question.

synapsesocial.com/papers/698c1ca1267fb587c655f32dhttps://doi.org/10.1155/pedi/6905472
Ask AI
Helpful
Bookmark
Share
View Full Paper